• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

1

CATEGORIES

  • 1

PRICE

0
0
0
1

PUBLISHED

0
0
0
1

PRODUCT TYPE

1

Search "Orphan Drugs in Europe: Pricing, Reimbursement, Funding and Market Access Issues, 2011 Edition" returned 1 results.

PRODUCT TITLE
Orphan Drugs in Europe: Pricing, Reimbursement, Funding & Market Access Issues, 2013 Edition Orphan Drugs in Europe: Pricing, Reimbursement, Funding & Market Access Issues, 2013 Edition - Product Thumbnail Image Special Offer Sale Banner

Orphan Drugs in Europe: Pricing, Reimbursement, Funding & Market Access Issues, 2013 Edition

The cost of treating rare disease in an age when austerity measures are hitting total healthcare funding across Europe is a highly controversial, even emotive subject. There is a clear and pressing...

October 2013
Loading Indicator

Our Clients

Credit Suisse Group Heinz Company Telenor Group Deutsche Bank AG Solvay S.A. APC by Schneider Electric Lindt & Sprüngli AG